Canadian Biotech Known For Psilocybin And Cannabinoid-Based Medicines In FDA Phase 3 Trial For Bucillamine-Based Oral Covid Treatment
(Photo by GEORGE FREY / AFP) (Photo by GEORGE FREY/AFP via Getty Images)
AFP via Getty Images
In July, CNBCs Meg Tirrelle broke the news on Twitter that Pfizer would be spending up to $1B on a new oral Covid treatment pill. The catch is that Pfizer threw…
